Citizens Financial Group Inc. RI Purchases Shares of 1,148 Chemed Corporation $CHE

Citizens Financial Group Inc. RI purchased a new stake in shares of Chemed Corporation (NYSE:CHE) in the second quarter, Holdings Channel.com reports. The institutional investor purchased 1,148 shares of the company’s stock, valued at approximately $535,000.

Several other institutional investors and hedge funds have also bought and sold shares of the business. Monetary Solutions Ltd purchased a new position in shares of Chemed during the fourth quarter valued at approximately $25,000. Los Angeles Capital Management LLC bought a new position in shares of Chemed during the fourth quarter valued at approximately $26,000. BOK Financial Private Wealth Inc. purchased a new stake in Chemed in the fourth quarter worth $27,000. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in Chemed in the second quarter worth $34,000. Finally, Versant Capital Management Inc boosted its holdings in Chemed by 7,500.0% in the second quarter. Versant Capital Management Inc now owns 76 shares of the company’s stock valued at $35,000 after acquiring an additional 75 shares in the last quarter. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Chemed Stock Up 1.3%

Shares of NYSE:CHE opened at $535.86 on Thursday. The firm has a market capitalization of $7.00 billion, a P/E ratio of 26.91, a P/E/G ratio of 2.00 and a beta of 0.51. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.89 and a current ratio of 0.91. The stock has a 50 day moving average price of $494.52 and a 200-day moving average price of $445.00. Chemed Corporation has a 52-week low of $365.20 and a 52-week high of $557.00.

Chemed (NYSE:CHE) last released its quarterly earnings results on Tuesday, July 28th. The company reported $6.06 earnings per share for the quarter, beating the consensus estimate of $5.60 by $0.46. The company had revenue of $673.25 million for the quarter, compared to analyst estimates of $665.04 million. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The firm’s revenue was up 8.8% on a year-over-year basis. During the same period in the previous year, the company posted $4.27 earnings per share. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. As a group, equities research analysts anticipate that Chemed Corporation will post 23.18 EPS for the current fiscal year.

Chemed Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 3rd. Investors of record on Monday, August 17th will be paid a $0.70 dividend. This represents a $2.80 annualized dividend and a dividend yield of 0.5%. The ex-dividend date is Monday, August 17th. This is a positive change from Chemed’s previous quarterly dividend of $0.60. Chemed’s dividend payout ratio (DPR) is 14.06%.

Insider Activity at Chemed

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction dated Monday, August 3rd. The shares were sold at an average price of $539.51, for a total transaction of $1,079,020.00. Following the completion of the transaction, the chief executive officer directly owned 70,418 shares of the company’s stock, valued at $37,991,215.18. This trade represents a 2.76% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Patrick P. Grace sold 190 shares of the business’s stock in a transaction dated Friday, July 31st. The stock was sold at an average price of $532.00, for a total transaction of $101,080.00. Following the sale, the director directly owned 3,533 shares in the company, valued at $1,879,556. The trade was a 5.10% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 3,537 shares of company stock valued at $1,782,654 in the last three months. Company insiders own 3.33% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on CHE shares. Oppenheimer boosted their price objective on shares of Chemed from $500.00 to $590.00 and gave the company an “outperform” rating in a research report on Friday, July 31st. Weiss Ratings upgraded shares of Chemed from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, July 17th. Zacks Research raised shares of Chemed from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. Royal Bank Of Canada lifted their target price on shares of Chemed from $436.00 to $548.00 and gave the company a “sector perform” rating in a research note on Thursday, July 30th. Finally, Bank of America reiterated a “neutral” rating on shares of Chemed in a research report on Wednesday, July 29th. One research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Chemed presently has an average rating of “Hold” and a consensus target price of $530.75.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.